Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developability Evaluation of Single-Domain Antibody-Chelator Conjugates for Diagnostic Radiotracers.

Antibodies (Basel, Switzerland)·2026
Same author

Hour-scale single-molecule imaging reveals dynamic assembly of the Wnt co-receptors LRP6 and ROR2 into common signalosomes.

Science signaling·2026
Same author

Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148].

Neoplasia (New York, N.Y.)·2026
Same author

Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer.

Scientific reports·2026
Same author

Polyelectrolyte Multilayer Coatings As a Tunable Tool to Control Inflammatory Response to Biomaterials in Vitro.

ACS applied bio materials·2025
Same author

[Focus on young researchers : A new section in Pathology].

Pathologie (Heidelberg, Germany)·2025

Related Experiment Video

Updated: Mar 15, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

Visualizing Epithelial-Mesenchymal Transition Using the Chromobody Technology.

Julia Maier1, Bjoern Traenkle1, Ulrich Rothbauer2

  • 1Pharmaceutical Biotechnology, Eberhard Karls University Tuebingen, Tuebingen, Germany.

Cancer Research
|September 17, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a novel chromobody technology to visualize vimentin dynamics during epithelial-mesenchymal transition (EMT). This method aids in understanding cancer metastasis and developing new antimetastatic therapies.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K

Related Experiment Videos

Last Updated: Mar 15, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K
Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Epithelial-mesenchymal transition (EMT) drives cancer metastasis by altering cell phenotypes.
  • Vimentin, an EMT biomarker, is overexpressed in epithelial cancers, correlating with poor patient survival and increased invasiveness.
  • Current methods lack the ability to effectively trace vimentin dynamics during EMT.

Purpose of the Study:

  • To review the relevance of chromobody technology for visualizing EMT-related processes.
  • To highlight the importance of monitoring vimentin dynamics in cancer research.
  • To discuss the potential of chromobodies in developing antimetastatic therapies.

Main Methods:

  • Utilized a novel intrabody (chromobody) approach.
  • Studied the spatiotemporal organization of endogenous vimentin.
  • Employed high-content imaging to monitor EMT induction.

Main Results:

  • Demonstrated the utility of chromobody technology for visualizing endogenous vimentin.
  • Showcased the spatiotemporal dynamics of vimentin during EMT.
  • Provided a method for detailed characterization of EMT-related processes.

Conclusions:

  • Chromobody technology offers a powerful tool for studying EMT in living systems.
  • Visualizing vimentin dynamics is crucial for understanding cancer progression and metastasis.
  • This approach facilitates the development of novel antimetastatic therapeutic strategies.